ALSTON & BIRD LLP for AMERICAN COLLEGE OF GASTROENTEROLOGY
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
The Patient Protection and Affordable Care Act, Pub. L. No. 111-148, Section 4104; Colon cancer screening policies in Medicare; Medicare physician quality incentives; Advancement of physician quality registries as they relate to Medicare physician payment reform; Transparency in valuation of medical procedures under Medicare; Issues related to the Medicare physician fee schedule and payment policies for GI services, including budget neutrality and Medicare Economic Index; H.R.8800 - Supporting Medicare Providers Act of 2022; in general - protecting access to physician services for Medicare beneficiaries per preventing reductions resulting from Medicare sequestration, Statutory PAYGO, and reduction in Medicare conversion factor for CY2023; physician burden reduction under Medicare, in general; H.R.1868/Pub. L. No. 117-7, To prevent across-the-board direct spending cuts, and for other purposes/Medicare sequester; Policies to waive cost of certain diagnostic colorectal cancer procedures under Medicare; Policies to continue coverage and payment for telehealth services under Medicare; S.610/Pub. L. No. 117-71, Protecting Medicare and American Farmers from Sequester Cuts Act; H.R.3173/S.3018, Improving Seniors' Timely Access to Care Act; H.R.7995, To amend title XVIII of the Social Security Act to exempt qualifying physicians from prior authorization requirements under Medicare Advantage plans, and for other purposes; H.R.2617, the Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| Y. BRIAN LEE | — |
| MICHAEL PARK | — |
| EARL POMEROY | — |
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
Health Issues HCR
S.464/H.R.2163, the Safe Step Act; H.R.1319/P.L. 117-2, American Rescue Plan Act of 2021-issues related to economic and regulatory relief for health care providers; issues related to coverage of products under drug formulary; policies reforming prior authorization of physician services; implementation of the No Surprises Act, P.L. 116-260; H.R.2617, the Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| Y. BRIAN LEE | — |
| MICHAEL PARK | — |
| MARK RAYDER | — |
| EMILY A SHAW | — |
Budget/Appropriations BUD
Funding for colorectal cancer screening and education; funding for research of colorectal cancer; H.R.2617, the Consolidated Appropriations Act, 2023.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARK RAYDER | — |
| ROBERT SIGGINS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.